BASECARE-B (02170) plans to implement an H-share full circulation plan.

date
20:09 12/05/2026
avatar
GMT Eight
Becon Medical-B (02170) announced that the board of directors has reviewed and approved the proposal to implement the full circulation of H shares, by converting a total of approximately 191 million shares of unlisted stock into H shares. Upon obtaining all relevant approvals and/or filings (including the approval of the China Securities Regulatory Commission and the listing of the Stock Exchange), and complying with all applicable laws, regulations, and rules, the unlisted shares will be converted into H shares, and the company will apply for approval to list and trade such H shares on the Stock Exchange main board.
BASECARE-B (02170) announced that the Board of Directors has reviewed and approved the proposal to implement the full circulation of H shares, by converting approximately 191 million shares of the company's unlisted shares into H shares. Upon obtaining all necessary approvals and/or filings (including the filing notice from the China Securities Regulatory Commission and the approval of the Stock Exchange), and in compliance with all applicable laws, regulations, and rules, these unlisted shares will be converted into H shares, and the company will apply for approval for the listing and trading of these H shares on the Main Board of the Stock Exchange.